221 related articles for article (PubMed ID: 33201403)
1. Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma.
Chen MF; Lu MS; Hsieh CC; Chen WC
Cell Oncol (Dordr); 2021 Apr; 44(2):373-384. PubMed ID: 33201403
[TBL] [Abstract][Full Text] [Related]
2. Porphyromonas gingivalis promotes progression of esophageal squamous cell cancer via TGFβ-dependent Smad/YAP/TAZ signaling.
Qi YJ; Jiao YL; Chen P; Kong JY; Gu BL; Liu K; Feng DD; Zhu YF; Ruan HJ; Lan ZJ; Liu QW; Mi YJ; Guo XQ; Wang M; Liang GF; Lamont RJ; Wang H; Zhou FY; Feng XS; Gao SG
PLoS Biol; 2020 Sep; 18(9):e3000825. PubMed ID: 32886690
[TBL] [Abstract][Full Text] [Related]
3. Associations of
Guo Y; Liu Y; Yang H; Dai N; Zhou F; Yang H; Sun W; Kong J; Yuan X; Gao S
Pathol Oncol Res; 2021; 27():1609976. PubMed ID: 34955686
[No Abstract] [Full Text] [Related]
4. Porphyromonas gingivalis promotes the motility of esophageal squamous cell carcinoma by activating NF-κB signaling pathway.
Meng F; Li R; Ma L; Liu L; Lai X; Yang D; Wei J; Ma D; Li Z
Microbes Infect; 2019; 21(7):296-304. PubMed ID: 30763763
[TBL] [Abstract][Full Text] [Related]
5.
Liang G; Wang H; Shi H; Zhu M; An J; Qi Y; Du J; Li Y; Gao S
ACS Infect Dis; 2020 May; 6(5):871-881. PubMed ID: 32298082
[TBL] [Abstract][Full Text] [Related]
6.
Wang X; Jia Y; Wen L; Mu W; Wu X; Liu T; Liu X; Fang J; Luan Y; Chen P; Gao J; Nguyen KA; Cui J; Zeng G; Lan P; Chen Q; Cheng B; Wang Z
Cancer Res; 2021 May; 81(10):2745-2759. PubMed ID: 34003774
[No Abstract] [Full Text] [Related]
7. Porphyromonas gingivalis infection exacerbates oesophageal cancer and promotes resistance to neoadjuvant chemotherapy.
Gao S; Liu Y; Duan X; Liu K; Mohammed M; Gu Z; Ren J; Yakoumatos L; Yuan X; Lu L; Liang S; Li J; Scott DA; Lamont RJ; Zhou F; Wang H
Br J Cancer; 2021 Aug; 125(3):433-444. PubMed ID: 33981017
[TBL] [Abstract][Full Text] [Related]
8.
Wen L; Mu W; Lu H; Wang X; Fang J; Jia Y; Li Q; Wang D; Wen S; Guo J; Dai W; Ren X; Cui J; Zeng G; Gao J; Wang Z; Cheng B
J Dent Res; 2020 Jun; 99(6):666-675. PubMed ID: 32298192
[TBL] [Abstract][Full Text] [Related]
9.
Jia X; Liu J; He Y; Huang X
Front Cell Infect Microbiol; 2022; 12():982636. PubMed ID: 36262185
[TBL] [Abstract][Full Text] [Related]
10. IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus.
Chen MF; Kuan FC; Yen TC; Lu MS; Lin PY; Chung YH; Chen WC; Lee KD
Oncotarget; 2014 Sep; 5(18):8716-28. PubMed ID: 25238263
[TBL] [Abstract][Full Text] [Related]
11. Porphyromonas gingivalis suppresses oral squamous cell carcinoma progression by inhibiting MUC1 expression and remodeling the tumor microenvironment.
Lan Z; Zou KL; Cui H; Zhao YY; Yu GT
Mol Oncol; 2024 May; 18(5):1174-1188. PubMed ID: 37666495
[TBL] [Abstract][Full Text] [Related]
12. 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling.
Chen PT; Hsieh CC; Wu CT; Yen TC; Lin PY; Chen WC; Chen MF
Mol Cancer Ther; 2015 Jun; 14(6):1365-75. PubMed ID: 25824337
[TBL] [Abstract][Full Text] [Related]
13. Oral infection with a periodontal pathogen alters oral and gut microbiomes.
Simas AM; Kramer CD; Weinberg EO; Genco CA
Anaerobe; 2021 Oct; 71():102399. PubMed ID: 34090994
[TBL] [Abstract][Full Text] [Related]
14. IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus.
Chen MF; Chen PT; Lu MS; Lin PY; Chen WC; Lee KD
Mol Cancer; 2013 Apr; 12():26. PubMed ID: 23561329
[TBL] [Abstract][Full Text] [Related]
15. Porphyromonas gingivalis increases the invasiveness of oral cancer cells by upregulating IL-8 and MMPs.
Ha NH; Park DG; Woo BH; Kim DJ; Choi JI; Park BS; Kim YD; Lee JH; Park HR
Cytokine; 2016 Oct; 86():64-72. PubMed ID: 27468958
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma.
Gao SG; Yang JQ; Ma ZK; Yuan X; Zhao C; Wang GC; Wei H; Feng XS; Qi YJ
BMC Cancer; 2018 Jan; 18(1):17. PubMed ID: 29298684
[TBL] [Abstract][Full Text] [Related]
17. Role of Porphyromonas gingivalis in oral and orodigestive squamous cell carcinoma.
Lamont RJ; Fitzsimonds ZR; Wang H; Gao S
Periodontol 2000; 2022 Jun; 89(1):154-165. PubMed ID: 35244980
[TBL] [Abstract][Full Text] [Related]
18. Prolonged and repetitive exposure to Porphyromonas gingivalis increases aggressiveness of oral cancer cells by promoting acquisition of cancer stem cell properties.
Ha NH; Woo BH; Kim DJ; Ha ES; Choi JI; Kim SJ; Park BS; Lee JH; Park HR
Tumour Biol; 2015 Dec; 36(12):9947-60. PubMed ID: 26178482
[TBL] [Abstract][Full Text] [Related]
19. Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by stimulating the release of neutrophil extracellular traps in the tumor immune microenvironment.
Guo ZC; Jing SL; Jia XY; Elayah SA; Xie LY; Cui H; Tu JB; Na SJ
Inflamm Res; 2024 May; 73(5):693-705. PubMed ID: 38150024
[TBL] [Abstract][Full Text] [Related]
20.
Tsai MS; Chen YY; Chen WC; Chen MF
J Cancer; 2022; 13(12):3358-3367. PubMed ID: 36186905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
